Skip to main content

Peer Review reports

From: Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death

Original Submission
11 Jan 2023 Submitted Original manuscript
20 Feb 2023 Reviewed Reviewer Report
7 Mar 2023 Reviewed Reviewer Report - K. Sreedhara Ranganath Pai
4 Apr 2023 Author responded Author comments - Afrah Fatthi Salama
Resubmission - Version 2
4 Apr 2023 Submitted Manuscript version 2
8 Apr 2023 Author responded Author comments - Afrah Fatthi Salama
Resubmission - Version 3
8 Apr 2023 Submitted Manuscript version 3
18 Apr 2023 Reviewed Reviewer Report - K. Sreedhara Ranganath Pai
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
25 Aug 2023 Editorially accepted
19 Sep 2023 Article published 10.1186/s12906-023-04142-1

You can find further information about peer review here.

Back to article page